Corbus Pharmaceuticals Holdings Inc

NASDAQ:CRBP   3:52:20 PM EDT
0.35
+0.02 (+5.58%)
Earnings Announcements

Corbus Pharmaceuticals Reports First Quarter 2022 Financial Results

Published: 05/10/2022 12:27 GMT
Corbus Pharmaceuticals Holdings Inc (CRBP) - Corbus Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update.
Q1 Loss per Share $0.08.
Revenue is expected to be $0.2 Million
Adjusted EPS is expected to be -$0.06

Next Quarter Revenue Guidance is expected to be $0.22 Million
Next Quarter EPS Guidance is expected to be -$0.06

More details on our Analysts Page.